From Medical Design & Outsourcing

• COVID-19’s mechanisms are becoming clearer, Abbott’s heart failure CMO says
  We still don’t fully understand why the SARS-CoV-2 virus is so transmissible and causes severe disease in some people but not others. But Dr. Philip Adamson, chief medical officer of Abbott’s heart failure business, said he’s amazed by how quickly we’re learning about COVID-19, building off our prior knowledge of coronaviruses and other viral pathogens.… […]
• Junkosha plans new medical plant by 2025 as expansion strategy accelerates
  NEWS RELEASE: Junkosha Plans New Medical Plant by 2025 as Expansion Strategy Accelerates Japanese fluoropolymer manufacturer Junkosha, best known for its peelable FEP Heat Shrink Tubing and PTFE Liners, is staying true to its word by actively expanding capacity across its interventional medical component manufacturing sites. The company has announced the building of a new… […]
• BioInteractions launches expanded medical product development partnership offering at MD&M West
  NEWS RELEASE: BioInteractions launches expanded medical product development partnership offering at MD&M West Organizations planning to bring a medical device to market should consider the benefits teams gain by using a single high-end consultancy as they navigate the entire product development process. BioInteractions, a leading U.K. biomaterial technology company, is launching its expanded Product Pathway… […]
• Teamvantage launches new parent company Velosity
  NEWS RELEASE: Teamvantage Launches New Parent Company: Velosity Teamvantage, an industry leader in state-of-the-art tool design and manufacture, injection molding, precision machining and contract manufacturing for the medical device market for more than 50 years, announced today from MD&M West 2023 the launch of its new parent company, Velosity. Velosity will now represent the entire… […]
• Edwards Lifesciences names Secant Group as its supplier of the year
  NEWS RELEASE: Edwards Lifesciences Awards Secant Group 2022 Supplier of the Year Secant Group, a leading innovator in the design, development, and manufacture of implantable medical textile components for medical devices, has been named 2022 Supplier of the Year by Edwards Lifesciences, the global leader in patient-focused medical innovations for structural heart disease and critical care… […]
• New ‘ultrasound tornado’ device breaks down blood clots
  Researchers at say a new tool and technique using “vortex ultrasound” could potentially break down blood clots in the brain. This sort of ultrasonic tornado eliminated clots formed in an in vitro model of cerebral venous sinus thrombosis (CVST). The researchers, based at North Carolina State University, say it worked more quickly than existing techniques.… […]
• Stratasys has its first FDA-cleared medical device
  Stratasys (NASDAQ: SSYS) today introduced its TrueDent resin for making 3D-printed dentures. TrueDent is the first FDA-cleared medical device for the company, which is based in Eden Prairie, Minnesota and Rehovot, Isreal. The Class II dental resin is made specifically for the fabrication of dental appliances, including removable dentures. The company had the resin developed… […]
• Honeywell introduces new bio-fiber for cardiovascular and orthopedic devices
  NEWS RELEASE: Honeywell introduces new ultra-fine denier medical grade bio fiber for cardiovascular and orthopedic devices New technology enables smaller, lighter and more durable minimally invasive surgical device design Honeywell today announced the addition of a new ultra-fine denier fiber to its Spectra ® Medical Grade (MG) BIO fiber portfolio. Spectra ® Ultra Fine (UF)… […]
• Qosina appoints former EssilorLuxottica exec as its EVP
  Qosina announced today that it’s appointed Lee Pochter as its executive vice president. Pochter has more than 20 years of expertise in product strategy, business development, sales, marketing and supply chain management. Most recently, he was VP of the Alternative Lens Group at EssilorLuxottica. “I look forward to the guidance Lee will bring to our… […]
• Trelleborg to expand biopharma manufacturing footprint in Europe
  NEWS RELEASE: Trelleborg to Expand its BioPharma Manufacturing Footprint in Europe Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities in Malta. This follows a multimillion-dollar investment initiated in 2022 to expand biopharma capacities in North America. Linda Muroski, President of Trelleborg Healthcare & Medical, says: “The site will… […]
• Ulbrich expands Braid Wire Accelerator program
  Ulbrich Specialty Wire Products (USWP) announced that it expanded its Braid Wire Accelerator program by making it available in Europe. North Haven, Connecticut-based Ulbrich’s e-commerce solution rapidly delivers round and flat wire materials for manufacturing needs. Customers can, through just a few clicks, see alloys in stock, select materials and add products to their cart.… […]